Cargando…

MR Features Based on LI-RADS Ver. 2018 Correlated with Cytokeratin 19 Expression in Combined Hepatocellular Carcinoma-Cholangiocarcinoma

PURPOSE: To investigate the significance of MR features based on the Liver Imaging Reporting and Data System (LI-RADS ver. 2018) for identifying the expression of cytokeratin 19 (CK-19) in patients with combined hepatocellular carcinoma-cholangiocarcinoma (cHCC-CCA) before surgery. PATIENTS AND METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Changwu, Ni, Xiaoyan, Lu, Xin, Wang, Yi, Qian, Xianling, Yang, Chun, Zeng, Mengsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387586/ https://www.ncbi.nlm.nih.gov/pubmed/34458204 http://dx.doi.org/10.2147/JHC.S325686

Ejemplares similares

Major and Ancillary Features According to LI-RADS in the Assessment of Combined Hepatocellular-cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2020)

Development and validation of combined Ki67 status prediction model for intrahepatic cholangiocarcinoma based on clinicoradiological features and MRI radiomics
por: Qian, Xianling, et al.
Publicado: (2023)

Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI
por: Liu, Xinai, et al.
Publicado: (2022)

Correlation analysis of MR elastography and Ki-67 expression in intrahepatic cholangiocarcinoma
por: Gao, Shanshan, et al.
Publicado: (2023)

Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma
por: Xiao, Yuyao, et al.
Publicado: (2023)

A Multi-Parametric Radiomics Nomogram for Preoperative Prediction of Microvascular Invasion Status in Intrahepatic Cholangiocarcinoma
por: Qian, Xianling, et al.
Publicado: (2022)

Subcentimeter Nodules with Diagnostic Hallmarks of Hepatocellular Carcinoma: Comparison of Pathological Features and Survival Outcomes with Nodules Measuring 1–2 cm
por: Huang, Peng, et al.
Publicado: (2023)

Prognosis of Primary Liver Cancer Based on LI-RADS Classification with Extracellular Agent-Enhanced MRI
por: Li, Yubo, et al.
Publicado: (2023)

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
por: Cannella, Roberto, et al.
Publicado: (2021)

CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma
por: Zhou, Yan, et al.
Publicado: (2022)

CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors
por: Huang, Zhe, et al.
Publicado: (2023)

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
por: Lee, Sunyoung, et al.
Publicado: (2020)

CT/MRI LI-RADS version 2018 versus CEUS LI-RADS version 2017 in the diagnosis of primary hepatic nodules in patients with high-risk hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2021)

Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS
por: Hu, Yi-Xin, et al.
Publicado: (2021)

CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017—Can Things Be Put Together?
por: Caraiani, Cosmin, et al.
Publicado: (2021)

Liver Imaging and Data System (LI-RADS) Version 2018 and Other Imaging Features in Intrahepatic Cholangiocarcinoma in Chinese Adults with vs. without Chronic Hepatitis B Viral Infection
por: Liang, Ying-ying, et al.
Publicado: (2021)

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)
por: Ding, Ying, et al.
Publicado: (2018)

LI-RADS Version 2018 Treatment Response Algorithm: Diagnostic Performance after Transarterial Radioembolization for Hepatocellular Carcinoma
por: Yoon, Jongjin, et al.
Publicado: (2021)

Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

LI-RADS ancillary features on contrast-enhanced ultrasonography
por: Dietrich, Christoph F., et al.
Publicado: (2020)

The MR Imaging of Primary Intrahepatic Lymphoepithelioma-like Cholangiocarcinoma: A Diagnostic Challenge
por: Liu, Yangyang, et al.
Publicado: (2023)

MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018
por: Zhang, Haiping, et al.
Publicado: (2022)

Correction to: Differentiation between combined hepatocellular cholangiocarcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017
por: Li, Chao-qun, et al.
Publicado: (2022)

Should Threshold Growth Be Considered a Major Feature in the Diagnosis of Hepatocellular Carcinoma Using LI-RADS?
por: Park, Jae Hyon, et al.
Publicado: (2021)

MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma
por: Ma, Xijuan, et al.
Publicado: (2020)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
por: Wang, Ruizhi, et al.
Publicado: (2023)

The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan
por: Lai, Yih-Shyong, et al.
Publicado: (2018)

Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma
por: Jiang, Hanyu, et al.
Publicado: (2019)

Up-to-Date Role of CT/MRI LI-RADS in Hepatocellular Carcinoma
por: Moura Cunha, Guilherme, et al.
Publicado: (2021)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
por: Sugimoto, Katsutoshi, et al.
Publicado: (2023)

Cytokeratin 20-positive hepatocellular carcinoma
por: Fanni, D., et al.
Publicado: (2009)

A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
por: Sheng, Ruofan, et al.
Publicado: (2021)

Machine Learning-Based CEMRI Radiomics Integrating LI-RADS Features Achieves Optimal Evaluation of Hepatocellular Carcinoma Differentiation
por: Liu, Hai-Feng, et al.
Publicado: (2023)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
por: Sugimoto, Katsutoshi, et al.
Publicado: (2020)

Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review
por: Voizard, Nicolas, et al.
Publicado: (2019)

Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?—a direct head-to-head meta-analysis
por: Wang, Hong, et al.
Publicado: (2023)

Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection
por: Shao, Shuo, et al.
Publicado: (2020)

Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS)
por: Bae, Jae Seok, et al.
Publicado: (2017)

Predictive machine learning model for microvascular invasion identification in hepatocellular carcinoma based on the LI-RADS system
por: Yang, Xue, et al.
Publicado: (2022)

Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience
por: Ciocalteu, Adriana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsvtvrcf8jb40pjalf1mqhcovg